Subscribe to Newsletter
Diagnostics Genetics and epigenetics, Omics

The RNA Revolution

sponsored by ACD

acdbio logo

Gene expression profiling yields many insights into the disease state, particularly in discovering those molecular indicators known as biomarkers. Indeed, the widespread application of transcriptomic techniques in cancer research over recent years has proven that, like protein, RNA is a rich source of clinically valuable biomarkers for diagnosis, prognosis and predicting therapeutic response. Although such approaches may identify many potential biomarkers, translating these discoveries into the clinic for routine measurement has traditionally been hindered by established analytical technologies. While it is commonplace to detect and visualize DNA and proteins in their native context within single cells, until now the best routine measurement tools for RNA have been those that detect and quantify RNA in solution, losing all morphological context. Times are changing, however, and the ‘RNA Revolution’ is here.

Receive content, products, events as well as relevant industry updates from The Pathologist and its sponsors.
Stay up to date with our other newsletters and sponsors information, tailored specifically to the fields you are interested in

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.

Register to The Pathologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Pathologist magazine